It’s time to stop buying into the great statin con, says Dr. Aseem Malhotra. The benefits have been greatly exaggerated and the side effects have been downplayed, as our knowledge is completely based on studies from the statin industry.
Apparently newer and more rigorously controlled studies (after 2006) on statins show overall no significant benefit at all.
Considering all this statins should probably only be prescribed to people at very high risk of heart disease (usually only people with preexisting disease). Certainly not to a large part of the healthy population.